Login / Signup

Real-World Effectiveness of Pegloticase Associated with Use of Concomitant Immunomodulatory Therapy.

Emily E HolladayAmy S MudanoFenglong XieJingyi ZhangTed R MikulsKenneth G SaagHuifeng YunBrian LaMoreauxMegan Francis SedlakJeffrey R Curtis
Published in: Arthritis care & research (2024)
Consistent with clinical trials, results from this large observational registry suggest that concomitant immunomodulatory drug use improves pegloticase persistence.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • systematic review
  • cross sectional
  • mesenchymal stem cells
  • cell therapy
  • phase iii